MEDX

MEDX aims for long-term capital growth through investments in global companies who are engaged in the broad health care sector. The portfolio may include companies of any market capitalization. Eligible securities must have at least 50% of their company revenue in medical research, pharmaceuticals, and medical technology. Such companies may include surgical and medical instrument manufacturers, and biotech names. The portfolio will emphasize companies whose activities specifically involve cancer research, treatment, and pharmaceutical development. Selection and weighting are based on the fund adviser's evaluation of a company's fundamentals, industrial position, and capital investments. During temporary periods, the fund may invest up to 100% of its assets in US short-term debt securities and money market instruments. The fund may invest up to 20% in convertibles and non-convertible high-yield bonds. The fund is actively managed and the adviser has full discretion in adjusting the portfolio.